Scientists describe how iron helps drive tumor development in colorectal cancer

by Michael Haederle,University of New MexicoTFRC is increased in human CRC and is positively correlated with the CTNNB1 protein expression. Detection of TFRC expression in human normal (n = 5–8)

Updated on: December 27,2023 10

Scientists describe how iron helps drive tumor development in colorectal cancer

by Michael Haederle,University of New MexicoTFRC is increased in human CRC and is positively correlated with the CTNNB1 protein expression. Detection of TFRC expression in human normal (n = 5–8)

Updated on:December 27,2023 10

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on: December 19,2023 26

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on:December 19,2023 26

Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

by Delthia Ricks , Medical XpressIn vitro characterization of in vivo / ex vivo-derived 4T1 metastatic cell lines. (A) Schematic representation of the procedure used to generate the 4T1-BM2 metastatic

Updated on: December 22,2023 9

Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

by Delthia Ricks , Medical XpressIn vitro characterization of in vivo / ex vivo-derived 4T1 metastatic cell lines. (A) Schematic representation of the procedure used to generate the 4T1-BM2 metastatic

Updated on:December 22,2023 9

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on: December 28,2023 5

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on:December 28,2023 5

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Updated on: October 30,2023 25

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Updated on:October 30,2023 25

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge

Updated on: December 18,2023 12

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge

Updated on:December 18,2023 12

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur

Updated on: January 08,2024 13

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur

Updated on:January 08,2024 13

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

Updated on: October 24,2023 6

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

Updated on:October 24,2023 6

Longer wait for some forms of cancer diagnosis for Black and Asian patients

byUniversity of ExeterSite-specific box and Whisker plots showing ethnic differences in the number of days to diagnosis (lower adjacent value, 25th, 50th, and 75th centiles, and upper adjacent v

Updated on: December 24,2023 12

Longer wait for some forms of cancer diagnosis for Black and Asian patients

byUniversity of ExeterSite-specific box and Whisker plots showing ethnic differences in the number of days to diagnosis (lower adjacent value, 25th, 50th, and 75th centiles, and upper adjacent v

Updated on:December 24,2023 12

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on: December 22,2023 20

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on:December 22,2023 20

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on: December 25,2023 9

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on:December 25,2023 9

Stage and receptor status can indicate a breast cancer survivor's risk of recurrence

Updated on: December 22,2023 10

Stage and receptor status can indicate a breast cancer survivor's risk of recurrence

Updated on:December 22,2023 10